The high level of DGKα and inhibited MAPK pathways can lead to the dysfunction of human tumor-infiltrating CD8+ T cells (pro-tumoral), which is reversible upon treatment with low-dose of IL-2 to suppress DGKα [123]. Here, DGKA is linked to neoplasm.